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Abstract This qualitative study explored the experiences
of Norwegian men after being identified as BRCA 1/2
mutation-positive. Only limited knowledge is available on
this topic; therefore, the aim of this study was to gain a
deeper insight from the men’s own perspectives. Data were
collected from in-depth interviews with 15 men and seven
of their partners. The participants described fear of cancer
development, and two main narrative patterns were iden-
tified: fear for their own health, including fear of devel-
oping cancer, and negative feelings about responsibility for
others’ health. The men expressed fear of developing
cancer themselves and described a need for genetic risk
information. They were also deeply concerned about how
the mutation might affect their children and other relatives.
There is a need for guidelines concerning genetic risk
information and follow-up programs for male BRCA 1/2
mutation carriers. This study adds valuable contextual
insights into their experiences of living with fear of cancer.
Keywords Breast and ovarian cancer  Male BRCA 1/2
mutation carriers  Male fear of developing cancer 
Men and genetic counselling  Men’s health
Introduction
Following the identification of the BRCA1 and BRCA2
genes, genetic testing has become available to both men and
women in families at risk for hereditary breast and ovarian
cancer (HBOC). Once the family-specific mutation is
known, family members may be identified as carriers or non-
carriers. Both male and female offspring of mutation carriers
have a 50% risk of inheriting the cancer-associated mutation.
However, the risk of developing cancer is much higher in
women than in men who carry the mutation. The lifetime risk
of developing breast cancer (BC) is estimated to be between
43 and 95% for female carriers [1]. They also have up to a
60% risk of developing ovarian cancer (OC). Variable risk
estimates have been reported, depending on whether the
studies are family- or case-ascertained. An established risk
management program for female BRCA1/2 mutation carri-
ers is available in Norway [2]. Men may also be identified as
mutation carriers, but the implications for BRCA1/2-posi-
tive men are still somewhat unclear. Male BRCA1/2 carriers’
risk of developing prostate cancer (PRCA) is estimated to be
6–14%, and BRCA2 mutation-positive men have an addi-
tional 6% risk of developing BC [1, 3]. In addition, the risks
of pancreatic, gastric and hematologic cancers have also
been reported to be higher in BRCA carriers than in non-
carriers [4]. There are conflicting data regarding the risk of
colorectal cancer and melanoma [4]. New research has also
suggested that BRCA1/2 mutation carriers may develop a
more aggressive form of PRCA [5, 6], and a more rapid
progression of PRCA in men with BRCA2 mutations has
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been reported [7]. It is thought that target screening to detect
cancer at an early clinical stage may be beneficial for these
men [5, 7]. However, risk management and counselling
strategies are still lacking [4].
Little research attention has been paid to male experi-
ences in HBOC families [8]. The sparse literature available
describes men as mainly seeking genetic testing out of an
obligation to their children [9–13], and it is reported that
women have a strong influence upon male decision-making
regarding genetic testing [11]. Previous evidence has
described the wives as responsible for revealing genetic
risk information in the family [12] and men as finding it
difficult to share unfavourable test results with their chil-
dren [12, 14–16]. Fear of developing cancer has also been
reported among men in HBOC families [10, 15–17], and
avoidance is said to be a coping strategy among these men
[15, 17].
The available studies regarding male experiences in
HBOC families report low rates of mutation carriers [8, 9,
11, 14]. As such, limited knowledge regarding the experi-
ences of BRCA1/2 mutation-positive men is available. The
aim of this study was to gain a deeper understanding of
male BRCA1/2 mutation carriers’ experiences. This
understanding may contribute to providing optimal care for
men in HBOC families who seek genetic counselling and
testing.
Methods
Sample
A letter of invitation was sent from two regional medical
genetics departments in Norway to 43 male BRCA1/2
mutation carriers in 19 families. The men were also invited
to include their current partners. In accordance with Nor-
wegian legislation, the men had attended genetic counsel-
ling both prior to testing and at the time the test results
were disclosed. They had not been offered any genetic
counselling after the disclosure of their test results, and
none of the participants were enrolled in follow-up pro-
grams at the time of the interviews.
Data collection and ethical issues
After approval by the Regional Research Ethics Committee
and Norwegian Social Sciences Data Services, data were
collected during two separate, in-depth interviews with a
minimum of 2 weeks between the interviews. The first
interview involved the men only. To obtain knowledge
about male–female communication and family dynamics,
the men’s current partners were invited to participate in the
second interview. The participating partners returned a
separate consent form. In cases where no partner was
participating, two separate interviews were performed with
the man. For practical reasons, one man was not able to
participate in the second interview. The participants were
offered a new genetic counselling session shortly after the
interviews were completed, and ten men accepted this
offer.
All the interviews were performed face to face and were
tape-recorded with consent. They lasted 40 min on average
and occurred in a hospital ward or other location according
to the participants’ preferences. Initially, an interview
guide with broad, key questions was used to explore the
subjects’ experiences with cancer in their families, male
identity, and thoughts about future follow-up programs.
They were also asked about how the genetic testing was
initiated and their experience with the genetic counselling
and testing process. In addition, the respondents were
encouraged to expound on issues important to them. In
most cases, a long narrative story was generated by initially
asking the participants to tell how they became aware of
the family mutation and their decision to perform genetic
testing. Their stories often started when they learned about
the mutation from family members and continued through
the process of genetic counselling and testing.
Analysis
Initially, the interviews were analysed using Giorgi’s
phenomenological approach. He describes four steps in his
analysis [18, 19]. First, it was important to get a sense of
the entire material by listening through the audiotapes and
repeatedly reading the transcripts. Then, meaning units
were identified. In the third step, the colloquial language in
each meaning unit was transformed into professional ter-
minology. Finally, all the transformed meaning units were
considered when they were synthesised into a condensed
description structured in themes describing the men’s
experiences. The first interviews were listened through
carefully prior to the second interview, and both interviews
were analysed simultaneously to explore the specific con-
text of their stories. Next, core themes were identified
across the participants’ stories. The data program Non-
numerical Unstructured Data Indexing, Searching, and
Theorising (NUDIST) was used to organise and analyse the
interview transcripts.
Four core themes were identified, and three of these have
been presented elsewhere [20]. The fourth core theme,
which concerns fear of cancer development, is presented in
this report. This core theme was identified early in the
interviews, and most of the participants returned to this issue
several times. As this core theme is the main finding in the
study, a narrative approach was utilised in the analysis to
gain a deeper contextual insight. This methodology makes it
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possible to focus on the participant’s specific story and
variations between stories [21]. Individuals may organise
non-systematic encounters into coherent stories to create
meaning from experience [22] or to describe human expe-
rience [23]. By following each participant’s storyline, we
were able to describe how the present is coloured by past
experiences and expectations of the future. Simultaneously,
as we are able to understand the individual stories in context,
we were also to recognise patterns in spite of variations. A
narrative story has been described as a meaningful whole
containing a beginning, middle and an end [24]. Hence, we
listened to the interviews through focusing on this core
theme as a story, according to the abovementioned time
structure.
Results
15 male mutation carriers from 12 families and seven of
their female partners participated in this study. The men
ranged in age from 26 to 73 (median = 51). Three men had
no current partners, eight had biological daughters, and one
had no children. The interviews were conducted between 2
and 8 years after the disclosure of their test results, and one
of the participants had developed prostate cancer.
In most cases a narrative story was generated by initially
asking the participants to tell how they became aware of
the family mutation and about their decision to undergo
genetic testing. The stories of fearing cancer development
began when the participants learned about the family
mutation. In the middle, they described the process of
genetic counselling and testing, as well as their emotional
reactions. Finally, they described their situation at the time
of the interviews. Two main narrative patterns, both char-
acterised by fear, were identified across the stories: fear for
one’s own health and fear for and negative feelings of
being responsible for others’ health. Two different stories,
representing typical features of the respondents, were
chosen to present the patterns. These two stories stand out
by their richness and clarity, and they stimulated us to
recognise patterns in spite of variations. Both patterns are
present in the participants’ stories. To describe variations in
the material, a brief sketch and some excerpts from the
other participants’ experiences follow each story.
Fear for one’s own health
‘‘Bill’’ is a man in his fifties, with several children and he
has recently become a grandfather. He also has several
siblings, and an elderly mother. His father and several male
and female relatives have died of cancer. He has a very busy
work situation, and the interviews took place in his hectic
work environments. Bill participated alone in both
interviews as his wife did not want participate in the study.
He expressed himself very openly and directly during the
two interviews, and he had obviously made many reflec-
tions regarding his mutation status. His story began when he
learned about the family mutation from a distant female
relative. Bill did not know how she had become aware of the
family mutation. He spent some time evaluating the situa-
tion before he decided to approach genetic testing, and he
had not involved his children in his decision-making pro-
cess prior to the genetic test. During the genetic counselling
and testing process, he learned that he was mutation-posi-
tive, whereas all his siblings turned out to be negative. Bill
explained that the knowledge of his mutation status led to a
change in his life. The information has made him more
anxious about the condition of his health and his cancer risk.
He was told that the mutation mainly had consequences for
females, information he did not take at face value. On the
contrary, Bill questions whether the existing knowledge
regarding males’ risk may be too scarce and adds that the
future may change such information:
… there must be something that researchers haven’t
yet found. I feel that in ten years’ time, a completely
different conversation between the health care pro-
vider and the mutation carrier will take place. I felt
that when I got the news about that gene, that there
must be something that happens with men too. It is
too good to be true that the cancer risk mainly con-
cerns women.
At the present, Bill feels that the knowledge about his
mutation status has made a change in his life, as he has
started to worry about the condition of his health and his
cancer risk. In addition, some of his friends have recently
developed cancer, and he points out that when something
happens to people he knows, it has an emotional impact on
himself as well, increasing his own cancer fear. He has
noticed what he interprets as possible cancer symptoms but
has not informed his doctor about his mutation status. He
also feels that his heart may be failing, and he suffers from
frightening symptoms:
… I’ve had a few strange things with my heart. They
have checked it, but they didn’t find anything. They
say that I am 100% healthy. I keep having these
strange muscle pains close to my heart, and that
makes me anxious. When the anxiety comes, I start
feeling anxious about everything else too in some
way.
His doctor has prescribed anti-anxiety medication, a
situation Bill finds humiliating. No new appointment has
been made with his doctor.
All his siblings turned out to be mutation-negative, and
Bill feels that they have not shown particular interest in
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him since the disclosure of their test results. He has not
informed his children about the family mutation, and at the
present, he feels quite lonely. Bill has not discussed his
mutation status and his emotional reactions with anyone
else except from his wife. He considers discussing health
issues or emotional reactions with male friends or relatives
as difficult. He now suspects that his father’s cancer was
caused by the family mutation, which he also connects to a
birth defect in one of his children, although none of his
children have undergone genetic testing.
Variation
The participants learned about the family mutation from
close or distant relatives. In some cases, the mutation was
revealed when close family members developed cancer.
Many expressed that they experienced emotional reactions
some time after receiving their test results and had felt a
need for emotional and informative support some time after
the disclosure of their mutation status:
Would have liked to have had a telephone number or
a contact person, for when some time has passed and
then call up and talk about how things are…
Another participant expressed his feelings of being left
alone after the genetic testing:
And then it’s like… where can you get…and then
you are like, finished (with the counselling process).
If you were a woman then…
The disclosure of the participants’ unfavourable test
results led to many questions regarding their own cancer
risk. Because they had learned about increased prostate
cancer risk, observing the color of their urine and focusing
on the frequency of urination was described. Other par-
ticipants did not worry on a daily basis, but a variety of
symptoms made them strongly aware of their mutation
status. On one hand, they expressed feelings of relief at not
being female; on the other, they envied the fact that women
would be entitled to follow-up programs. Some described
feeling jealous when others had extensive health check-
ups. The participants associated other diseases and dis-
abilities with the family mutation and seemed to connect
all familial cancer to the family mutation. However, they
did experience that mutation-negative family members also
developed cancer:
My father also had another brother who did not carry
the mutation, but he had colon and lung cancer and
died from that even though he didn’t have the
mutation. That says to me, ok, you don’t have to have
the mutation to get sick. I won’t say that it makes me,
I feel sorry that he is dead now, but it is good to know
he didn’t have the mutation. That feels like something
remotely positive.
Most participants questioned their potential risk during
the interviews and wanted to receive information on a
regular basis, as they expected knowledge to increase in the
future.
Fear and bad feelings of being responsible for others’
health
‘‘Stuart,’’ an elderly man, participated alone in the two
separate interviews. His wife did not want to participate in
the study. Initially he expressed an unmet need of infor-
mation, and was admitted to future genetic counselling after
completion of the interviews. In the first interview Stuart
seemed a little anxious, but in the second interview 3 weeks
later he seemed to be more comfortable with the interview
situation. During both interviews he mainly focused on his
daughters’ cancer risk, and constantly returned to this issue
even when other issues were explored.
Stuart comes from a large family and has many siblings,
several children and many grandchildren. He suffered the
loss of his mother from cancer when he was a teenager:
Yes, I was about fifteen-sixteen years old. We were
many siblings, and I was not the oldest, several were
younger than me, and the youngest was six or seven
years old.
His grand-mother and several other female relatives also
died from cancer. He learned about the family mutation
when one of his daughters developed cancer at a young
age:
She called. We heard that she had a lump and that she
had had it removed, taken the test then and when the
result came, then she knew. Yes, that’s how we found
out. And of course, that was a shock.
Stuart‘s wife and daughter informed both close and
distant relatives about the family mutation immediately
after they learned about their daughter‘s mutation status.
Stuart and some of his siblings approached genetic coun-
selling and testing together. He described how they trav-
elled together and supported one another when they went to
see a genetic counsellor.
During the genetic counselling and testing process,
Stuart learned the difficult truth that he had passed on the
mutation to several of his daughters. He started to worry
about his daughters’ cancer risk and is at present still
focusing on his daughters’ health, hoping that they will do
everything possible to reduce their risk. His wife is
involved in their daughters’ decision-making regarding
genetic testing and prophylactic surgery, but he is usually
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not included in these discussions. Stuart is in need of
information regarding his daughters’ actual risks and risk
reduction options but does not know where to address these
questions. He finds it difficult to discuss his daughters’
actual risks with his wife. Stuart also questions his
daughters’ reproductive decision-making and worries that
they may develop cancer before they undergo prophylactic
surgery. One of his daughters is in her midst thirties and
has no children, and has expressed that she feels that she is
keeping her ovaries on ‘‘overtime.’’
Several of his siblings were also identified as mutation
positive, and some younger children in the extended family
developed different types of cancer in their childhood.
Stuart worries that his grandchildren also may be at risk
due to the family mutation. He sees the future of his
daughters and grandchildren as unsafe and unpredictable.
Stuart has noticed prostate problems and has tried to dis-
cuss his mutation status and potential risk with his doctor,
who has revealed scarce knowledge about this issue. Stuart
feels left quite alone with his questions.
Variation
Most participants expressed concern for their children as
their main motivation for testing, and they described
reacting emotionally when they learned about their muta-
tion status:
Yes, then you get those thoughts that you hope it
won’t, that my children, that you have been so lucky
that they didn’t get it since they had kids with people
outside the family. So, it is a downer, there is no
doubt about that.
The participants described being deeply concerned
about their sisters and daughters, and feelings of guilt were
expressed, especially in relation to daughters. Some had
closely followed their daughters’ genetic counselling and
testing process:
She was pretty quick to take action and took the test.
It was a tense time, it was almost like getting the
results back from an exam you thought you struggled
with.
Some of the participants’ mothers had developed can-
cer, and the men were worried about their mothers’
future. Concern for how this risk information would affect
their siblings was also expressed. They felt a sense of
responsibility towards those family members (especially
brothers) who they knew would have difficulties in coping
with an unfavourable test result. They also described their
concern for family members who did not want genetic
testing or did not communicate the risk information to
their offspring.
Discussion
The participants in the present study expressed fears of
developing cancer and a need for genetic risk information.
Feelings of responsibility for other family members’ health
were also described, accompanied by feelings of guilt.
None of the participants had been offered additional
genetic counselling after the disclosure of their test results,
and they expressed a need for updated genetic risk infor-
mation. The participants questioned if the existing risk
information was trustworthy or if new information about
male risk might be revealed in the future. Many of the men
described observing their urine on a daily basis, and some
had noticed prostate problems.
Little is known about BRCA1/2-positive males, and the
few available studies regarding men in HBOC families
have reported low rates of male participation among
mutation carriers [8]. Two studies have reported that the
motivation for genetic testing among men in HBOC fam-
ilies was fear of cancer or worries about their own health
[15, 16], and only one study has focused solely on BRCA1/
2 mutation-positive men [10]. In contrast, another study
has reported low levels of cancer fear among males testing
for BRCA1/2 [13]. Evidence suggests that cancer amongst
their family members may influence men’s feelings of risk
[15], and the loss of close female relatives causes intrusive
feelings of unresolved grief among men in HBOC families
[10, 15–17]. However, it has been found that most men
with unaffected mothers in HBOC families also viewed
themselves as being at increased risk [10].
None of the participants were included in surveillance
programs at the time of the interviews, and they experi-
enced their future as unsafe and unpredictable. According
to Antonovsky [25], it is important to have some influence
on one’s own future and fate to experience life as mean-
ingful, which is the main dimension in Antonovsky’s sense
of coherence (SOC) model. SOC is related to quality of life
and perceived health, and it develops throughout one’s life
[26]. One of the constituents of this model is comprehen-
sibility, which refers to whether experiences are perceived
as structured, predictable, and explainable. This is con-
sidered important in coping with health-related issues.
Coping strategies may have a significant impact on psy-
chological and physical health among persons at risk [27].
Knowledge about male risk and risk reduction options may
be crucial for enhancing comprehensibility. Bill clearly
expressed that he did not have sufficient information, and
he suspected that different risk information would be
revealed in the future. The insufficient information seemed
to make him less able to deal with his situation. Another
component of Antonovsky’s theory is manageability,
which requires individuals’ ability to perceive available
resources. From Bill’s story, we learned that most
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participants experienced a lack of confidence in their
general practitioners (GP). Bill did not inform his doctor
about his mutation status, despite suffering from what he
interpreted as possible cancer symptoms. This lack of trust
may have prevented the men from regarding their general
practitioners’ as available resources. Their reluctance to
discuss genetic information with their local GPs may also
be due to fear of being stigmatised [20]. Additionally, men
have been described as less able to communicate their
BRCA1/2 test results compared to women [28]. The men’s
lack of confidence in their GPs due to doctors’ lack of
genetic knowledge is consistent with findings amongst
women in HBOC families [29]. However, in contrast to
males, BRCA1/2 mutation-positive females are included in
risk management programs.
The participants described feeling responsible for the
health of other family members. Anxiety about passing on
a genetic condition to children has also been described in
other studies [12, 17, 30]. Most of the participants claimed
that they underwent the genetic test out of concern for their
children. This reasoning is consistent with other studies [9–
13]. We learned from Stuart’s story that he is concerned
about his daughters’ cancer risk and is in need of infor-
mation regarding their actual risks and risk reduction
options. According to Antonovsky’s theory [25], this
information is necessary to enhance comprehensibility
when, for instance, illness or increased risk of illness
strikes. Stuart also reported that his wife is involved in
discussions with his daughters regarding risk reduction
options, but he is not included in these discussions. He
feels that the future is unsafe and unpredictable for his
daughters and grandchildren. According to the SOC model,
it is essential to have some influence on fate to experience
the actual situation as meaningful [25]. It has also been
shown in previous studies that men in HBOC families may
be excluded from family conversations about female can-
cer [15] and that few males participate in female conver-
sations about prophylactic surgery [10]. The men in this
study also expressed concerns about relatives who they felt
would be unable to cope with unfavourable test results; this
concern has also been reported for women [29].
The male counselling and genetic testing process is
often initiated by female relatives [10], and it is possible
that the men may not have been aware of their own
potential cancer risk prior to this process. It has been found
that introducing future risk information about diseases may
be harmful and can lead to insecurity [31–33]. Evidence
suggests that mutation carriers should be counselled about
issues such as lifestyle and self-examination techniques.
The increased risk of other malignancies should also be
discussed with male mutation carriers [4]. However, this
discussion might increase their fear of developing cancer if
no management strategies are available. The emotional
impact of genetic risk information has been described as
depending on the possibility of having any control over the
course of the genetic condition [30], which is in accordance
with the manageability component of the SOC model. In
accordance with studies reporting men’s interest in support
groups and need of additional genetic counselling after
predictive testing for BRCA1/2 [10, 34], many participants
accepted the offer of future genetic counselling after
completion of the interviews.
Methodological considerations
One important way for individuals to make sense of and
give meaning to individuals is to organise experiences into a
narrative form [35]. In this case, the narrative stories con-
tributed to the participants’ understanding of their own
experiences as BRCA1/2 mutation carriers. The study of the
participants’ responses as narratives and the effort to
empower these men are therefore closely related [35]. The
interviews were conducted by the first author, who is a
professional genetic counsellor with long-standing experi-
ence in cancer counselling. This experience may have
enhanced the communication with the participants. The
participation rate in the study was low, and it is a possibility
that only men with strong cancer worries participated in the
study. However, other studies have also reported low rates
of male participation among mutation carriers [8]. Further
investigations of male cancer worry among BRCA1/2
mutation carriers should be conducted in other populations,
using both qualitative and quantitative study designs.
Conclusions
The results of this study indicated that there is a need for
guidelines concerning genetic counselling, risk information
and follow-up programs for male BRCA1/2 carriers.
Information about risk reduction options and surveillance
programs for women should also be included in genetic
counselling sessions for men.
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